Cite
HARVARD Citation
Kolovou, G. et al. (2020). Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia. European journal of preventive cardiology. pp. 157-165. [Online].